You make great points pokey! Btw I was heading to get a tooth pulled at the dentist today, and I was listening to Jim Cramer on CNBC. They were talking about Gilead buying Immunomesics. Cramer said Gilead was way overpaying and maybe showing they are in trouble and need to buy future business. That Gilead won’t make money on them until maybe 2023 which is nuts. Plus he made the comment that rings regarding the rush to buy companies with cures. He said you want to buy maintenance and not cures! So this is why companies like GNBT, with possible cures, gets no love from big pharmaceutical. Also why Altucell is still a deal with us, probably because big pharmaceutical doesn’t want a cure for type 1 diabetes. But we shouldn’t over pay for it either.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.